$KEQU

HULL THOMAS DAVID III sold (to issuer) $616K of KEQU

HULL THOMAS DAVID III (President & CEO) sold (to issuer) 17,000 shares of KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) at $36.25 ($0.62M total) on 2026-06-30.

Original reporting
SEC EDGAR · HULL THOMAS DAVID III
Published Jul 2, 2026, 3:47 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 2, 2026, 3:51 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$KEQU
Neutral
medium confidence
Mentioned
$KEQU
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$KEQUNeutralLow
01

Why it matters

The newest fact is the CEO’s sale of 17,000 shares at $36.25 to the issuer on 2026-06-30, totaling $616,250; no other company-specific developments are provided.

02

Market read

Primarily a sentiment/positioning datapoint from insider activity; not a fundamental catalyst.

03

What to watch

No 10b5-1 plan is indicated, but the filing doesn’t clarify intent; traders should watch for follow-on insider buys/sales or other contemporaneous corporate actions.

Relevance 5/10Novelty 5/10Timing: new Form 4 filed 2026-07-02 (after-hours/late day)

Background

The filing is an SEC Form 4 insider transaction for KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU).

Company-level read

Ticker impact

$KEQUNeutralMedium confidence
Context

KEQU CEO/President sold 17,000 shares to the issuer at $36.25 on 2026-06-30, disclosing $616,250 in insider selling activity.

Expected impact

Low likelihood of a sustained price move; any impact would be short-lived unless followed by additional disclosures.

Evidence & confidence

Form 4 is a primary filing and the transaction is specific, but the article provides no new fundamentals, guidance, or enforcement/contract catalyst—only an insider sale to issuer.

Market effects

No sector read-across; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Because the sale is coded as “to issuer” (often buyback participation), it may be mechanical rather than a bearish signal.

Key entities

  • KEWAUNEE SCIENTIFIC CORP /DE/

    Subject of the Form 4 insider transaction; ticker KEQU.

  • HULL THOMAS DAVID III

    President & CEO; sold shares to the issuer per the Form 4.

Related articles

$KEQUMed

KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU): Results of Operations and Financial Condition

KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 prfy26q4earningsrelease.htm EX-99.1 Document Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III 704/871-3274 STATESVILLE, N.C. June 23, 2026 – PRNewswire / Kewaunee Scientific Corporation (NASDAQ